This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Andrew Falconbridge
Vice President of Process Technology and Innovation at Alvotech


Graduate in Biochemistry with over 30 years in the Biotechnology industry. During that time have worked in manufacturing, development, business improvement and operational excellence. Started career at  Wellcomes then to  Genzyme before moving to Alvotech where has been for 6 years. currently Vice President  of Process Technology and Innovation, responsible for driving new technologies, innovation and process improvements in Alvotech development and manufacturing.

Agenda Sessions

  • Using Hybrid Continuous Biomanufacturing Approaches to increase efficiency and decrease cost in the manufacture of Biosimilars

  • Hybrid Approaches to Continuous Manufacturing